Processing of nano boron carbide reinforced flexible polymer composites with improved shielding properties

Aims: The main objective of the current research is to develop light-weight and flexible electromagnetic shielding materials with improved properties using nano/mikro boron carbide dispersed into polymer based matrices after surface modification. Methods: Nano/micro boron carbide particles with various morphologies were synthesized by sol-gel techniques and the obtained particles were surface modified with different functional groups. After mixing the particles with different polymers using high shear mixer, shielding composite plates were shaped using injection moulding and warm pressing. Results: It was shown that sol-gel technique was able to produce boron carbide particles with controlled morphology and better shielding properties could be obtained using these particles within polymeric matrices leading to the formation of flexible composites. Conclusions: Overall, it was found that light-weight and effective shielding materials could be obtained using boron carbide particles dispersed within polymeric matrices. Surface modification of the particles is critical for good dispersion and hence to get better final properties. The concentration of the reinforcing particles also affects the properties in terms of energy absorption and shielding

Processing and properties of new generation radiation shielding nano composites

Electromagnetic radiation from equipments in medical diagnostic centers or nuclear reactors causes ionization including gamma rays and x-rays that are well known to be very harmful to human health. Therefore, flexible, light-weighed and environmentally friendly shielding materials that can replace toxic and very heavy Pb based materials are required. In the present work, synthesized and surface modified micro/nano B4C particles are distributed within polymeric matrices in order to obtain flexible shielding materials. The effect of surface functionalization and concentration of boron carbide on the distribution characteristics of boron carbide and the final properties of the composites are examined

Processing of surface modified nano boron carbide (B4C) containing flexible composites as shielding materials

Aims: The main aim of the work is to synthesize nano boron carbide using cost effective modified sol-gel technique and then functionalize the obtained nanoparticles surface so that they can be homogeneously distributed within flexible polymeric matrices for radiation shielding purposes. Methods: Different starting chemicals were used in sol gel technique to obtain nano boron carbide (B4C) particles with controlled size and morphology. Surface modification with various functional groups was conducted on the synthesized particles and final coated B4C particles were embedded within the polymers using high shear mixing process in the form of thin sheets and plates. Results: It was shown first that nano boron carbide particles can be obtained by a novel modified sol gel technique using nano elemental boron which results in obtaining stoichiometric boron carbide. Surface modified B4C with functional groups resulted in the excellent distribution within polymeric matrices leading to the improvement in both mechanical and shielding properties. Conclusions: Size and morphology controlled B4C can improve the mechanical and shielding properties of polymer based composites. The final obtained composite materials are considered to be suitable candidate for lightweight radiation shielding materials

Magnetic properties, anisotropy, and microstructure of sputtered rare-earth iron multilayers

A study of compositionally modulated magnetic films of the form Fe/RE, particularly for RE=Nd and Dy, has been performed by vibrating sample magnetometry, ac susceptibility and x-ray diffraction. The relationship between the magnetic properties and the layer thickness was studied systematically for X-Å Fe/Y-Å Dy, as the layer thicknesses X and Y were varied from 1.8 to 20 Å. The ranges of layer thicknesses required for perpendicular anisotropy were determined. The interface and volume anisotropy energies were estimated for X-Å Fe/Y-Å Nd and the differences in the magnetic properties between X-Å Fe/7-Å Dy and X-Å Fe/7-Å Nd are discussed. Journal of Applied Physics is copyrighted by The American Institute of Physics

Timeliness of Clinic Attendance is a good predictor of Virological Response and Resistance to Antiretroviral drugs in HIV-infected patients

Ensuring long-term adherence to therapy is essential for the success of HIV treatment. As access to viral load monitoring and genotyping is poor in resource-limited settings, a simple tool to monitor adherence is needed. We assessed the relationship between an indicator based on timeliness of clinic attendance and virological response and HIV drug resistance

Context-dependent compensation among phosphatidylserine-recognition receptors

Phagocytes express multiple phosphatidylserine (PtdSer) receptors that recognize apoptotic cells. It is unknown whether these receptors are interchangeable or if they play unique roles during cell clearance. Loss of the PtdSer receptor Mertk is associated with apoptotic corpse accumulation in the testes and degeneration of photoreceptors in the eye. Both phenotypes are linked to impaired phagocytosis by specialized phagocytes: Sertoli cells and the retinal pigmented epithelium (RPE). Here, we overexpressed the PtdSer receptor BAI1 in mice lacking MerTK (Mertk(-/-) Bai1(Tg)) to evaluate PtdSer receptor compensation in vivo. While Bai1 overexpression rescues clearance of apoptotic germ cells in the testes of Mertk(-/-) mice it fails to enhance RPE phagocytosis or prevent photoreceptor degeneration. To determine why MerTK is critical to RPE function, we examined visual cycle intermediates and performed unbiased RNAseq analysis of RPE from Mertk(+/+) and Mertk(-/-) mice. Prior to the onset of photoreceptor degeneration, Mertk(-/-) mice had less accumulation of retinyl esters and dysregulation of a striking array of genes, including genes related to phagocytosis, metabolism, and retinal disease in humans. Collectively, these experiments establish that not all phagocytic receptors are functionally equal, and that compensation among specific engulfment receptors is context and tissue dependent

Study of e+e−→ppˉe^+e^- \rightarrow p\bar{p} in the vicinity of ψ(3770)\psi(3770)

Using 2917 $\rm{pb}^{-1}$ of data accumulated at 3.773~$\rm{GeV}$, 44.5~$\rm{pb}^{-1}$ of data accumulated at 3.65~$\rm{GeV}$ and data accumulated during a $\psi(3770)$ line-shape scan with the BESIII detector, the reaction $e^+e^-\rightarrow p\bar{p}$ is studied considering a possible interference between resonant and continuum amplitudes. The cross section of $e^+e^-\rightarrow\psi(3770)\rightarrow p\bar{p}$, $\sigma(e^+e^-\rightarrow\psi(3770)\rightarrow p\bar{p})$, is found to have two solutions, determined to be ($0.059\pm0.032\pm0.012$) pb with the phase angle $\phi = (255.8\pm37.9\pm4.8)^\circ$ ($<$0.11 pb at the 90% confidence level), or $\sigma(e^+e^-\rightarrow\psi(3770)\rightarrow p\bar{p}) = (2.57\pm0.12\pm0.12$) pb with $\phi = (266.9\pm6.1\pm0.9)^\circ$ both of which agree with a destructive interference. Using the obtained cross section of $\psi(3770)\rightarrow p\bar{p}$, the cross section of $p\bar{p}\rightarrow \psi(3770)$, which is useful information for the future PANDA experiment, is estimated to be either ($9.8\pm5.7$) nb ($<17.2$ nb at 90% C.L.) or $(425.6\pm42.9)$ nb

Analytical techniques for multiplex analysis of protein biomarkers

Introduction: The importance of biomarkers for pharmaceutical drug development and clinical diagnostics is more significant than ever in the current shift toward personalized medicine. Biomarkers have taken a central position either as companion markers to support drug development and patient selection, or as indicators aiming to detect the earliest perturbations indicative of disease, minimizing therapeutic intervention or even enabling disease reversal. Protein biomarkers are of particular interest given their central role in biochemical pathways. Hence, capabilities to analyze multiple protein biomarkers in one assay are highly interesting for biomedical research. Areas covered: We here review multiple methods that are suitable for robust, high throughput, standardized, and affordable analysis of protein biomarkers in a multiplex format. We describe innovative developments in immunoassays, the vanguard of methods in clinical laboratories, and mass spectrometry, increasingly implemented for protein biomarker analysis. Moreover, emerging techniques are discussed with potentially improved protein capture, separation, and detection that will further boost multiplex analyses. Expert commentary: The development of clinically applied multiplex protein biomarker assays is essential as multi-protein signatures provide more comprehensive information about biological systems than single biomarkers, leading to improved insights in mechanisms of disease, diagnostics, and the effect of personalized medicine

Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers.

Genetic studies of type 1 diabetes (T1D) have identified 50 susceptibility regions, finding major pathways contributing to risk, with some loci shared across immune disorders. To make genetic comparisons across autoimmune disorders as informative as possible, a dense genotyping array, the Immunochip, was developed, from which we identified four new T1D-associated regions (P < 5 × 10(-8)). A comparative analysis with 15 immune diseases showed that T1D is more similar genetically to other autoantibody-positive diseases, significantly most similar to juvenile idiopathic arthritis and significantly least similar to ulcerative colitis, and provided support for three additional new T1D risk loci. Using a Bayesian approach, we defined credible sets for the T1D-associated SNPs. The associated SNPs localized to enhancer sequences active in thymus, T and B cells, and CD34(+) stem cells. Enhancer-promoter interactions can now be analyzed in these cell types to identify which particular genes and regulatory sequences are causal.This research uses resources provided by the Type 1 Diabetes Genetics Consortium, a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute of Allergy and Infectious Diseases (NIAID), the National Human Genome Research Institute (NHGRI), the National Institute of Child Health and Human Development (NICHD) and JDRF and supported by grant U01 DK062418 from the US National Institutes of Health. Further support was provided by grants from the NIDDK (DK046635 and DK085678) to P.C. and by a joint JDRF and Wellcome Trust grant (WT061858/09115) to the Diabetes and Inflammation Laboratory at Cambridge University, which also received support from the NIHR Cambridge Biomedical Research Centre. ImmunoBase receives support from Eli Lilly and Company. C.W. and H.G. are funded by the Wellcome Trust (089989). The Cambridge Institute for Medical Research (CIMR) is in receipt of a Wellcome Trust Strategic Award (100140). We gratefully acknowledge the following groups and individuals who provided biological samples or data for this study. We obtained DNA samples from the British 1958 Birth Cohort collection, funded by the UK Medical Research Council and the Wellcome Trust. We acknowledge use of DNA samples from the NIHR Cambridge BioResource. We thank volunteers for their support and participation in the Cambridge BioResource and members of the Cambridge BioResource Scientific Advisory Board (SAB) and Management Committee for their support of our study. We acknowledge the NIHR Cambridge Biomedical Research Centre for funding. Access to Cambridge BioResource volunteers and to their data and samples are governed by the Cambridge BioResource SAB. Documents describing access arrangements and contact details are available at http://www.cambridgebioresource.org.uk/. We thank the Avon Longitudinal Study of Parents and Children laboratory in Bristol, UK, and the British 1958 Birth Cohort team, including S. Ring, R. Jones, M. Pembrey, W. McArdle, D. Strachan and P. Burton, for preparing and providing the control DNA samples. This study makes use of data generated by the Wellcome Trust Case Control Consortium, funded by Wellcome Trust award 076113; a full list of the investigators who contributed to the generation of the data is available from http://www.wtccc.org.uk/.This is the author accepted manuscript. The final version is available via NPG at http://www.nature.com/ng/journal/v47/n4/full/ng.3245.html